Psychopharmacology

, Volume 232, Issue 4, pp 683–697 | Cite as

Activation of serotonin 5-HT2A receptors inhibits high compulsive drinking on schedule-induced polydipsia

  • Silvia Victoria Navarro
  • Valeria Gutiérrez-Ferre
  • Pilar Flores
  • Margarita Moreno
Original Investigation
First Online:
Received:
Accepted:

Abstract

Rationale

Schedule-induced polydipsia (SIP) is an established model for studying compulsive behaviour in rats. Serotoninergic drugs effectively reduce compulsive drinking on SIP, and high compulsive drinker rats selected by SIP have shown differences in serotoninergic brain activity. However, the specific serotoninergic receptors that modulate compulsive SIP remain unclear.

Objective

We investigated the functional role of serotonin 5-hydroxytryptamine 2A or C (5-HT2A/C) receptors in compulsive SIP behaviour.

Methods

Rats were selected for low (LD) versus high drinking (HD) behaviour on SIP. The effects of the systemic administration of the selective serotonin reuptake inhibitor citalopram, selective norepinephrine reuptake inhibitor atomoxetine, serotonin 5-HT2A/C receptor agonist DOI hydrochloride ((±)-2,5-dimethoxy-4-iodoamphetamine), serotonin 5-HT2C receptor antagonist SB242084, serotonin 5-HT2A receptor antagonist ketanserin and M100907 were assessed on SIP. Subsequently, the effects of DOI were tested after the pre-administration of SB242084, ketanserin and M100907 on SIP.

Results

Citalopram and DOI reduced compulsive drinking in HD compared with LD rats on SIP. In contrast, SB242084 increased compulsive drinking in HD compared with LD rats on SIP. Atomoxetine, ketanserin and M100907 had no effect on SIP. The reduction in water intake produced by DOI was blocked by ketanserin and M100907, but not by SB242084 administration, in HD rats.

Conclusions

These findings highlight the contribution of serotoninergic 5-HT2A/C receptors compared with noradrenergic mechanisms on SIP and reveal the “therapeutic” activation of serotonin 5-HT2A in the inhibition of the compulsive drinking behaviour in HD rats. Thus, it may represent a potentially new marker of vulnerability and provides additional insight for potential treatments on compulsive behaviours in neuropsychiatric populations.

Keywords

Schedule-induced polydipsia Compulsivity Serotonin Serotonin 5-HT2A receptor Serotonin 5-HT2C receptor Obsessive–compulsive disorder Animal model 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

This study was funded by a grant from the Ministerio de Economía y Competitividad, Spanish Government (PSI2012-31660). The authors thank Luis Ruedas for his invaluable and continuous help.

Conflicts of interest

The authors declare no conflict of interest.

References

  1. Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S, Bolwig TG, Knudsen GM (2005) Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol 8:391–401PubMedCrossRefGoogle Scholar
  2. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Press, Washington DCCrossRefGoogle Scholar
  3. Angoa-Pérez M, Kane MJ, Briggs DI, Sykes CE, Shah MM, Francescutti DM, Rosenberg DR, Thomas DM, Kuhn DM (2012) Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity. J Neurochem 121:974–984. doi: 10.1111/j.1471-4159.2012.07739.x PubMedCentralPubMedCrossRefGoogle Scholar
  4. Aznar S, Klein AB (2013) Regulating prefrontal cortex activation: an emerging role for the 5-HT2A serotonin receptor in the modulation of emotion-based actions? Mol Neurobiol 48:841–853. doi: 10.1007/s12035-013-8472-0 PubMedCrossRefGoogle Scholar
  5. Baarendse PJ, Vanderschuren LJ (2012) Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats. Psychopharmacology (Berl) 2:313–326. doi: 10.1007/s00213-011-2576-x CrossRefGoogle Scholar
  6. Bari A, Eagle DM, Mar AC, Robinson ES, Robbins TW (2009) Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology 205:273–283. doi: 10.1007/s00213-009-1537-0 PubMedCentralPubMedCrossRefGoogle Scholar
  7. Bokor G, Anderson PD (2014) Obsessive-compulsive disorder. J Pharm Pract 2:116–130. doi: 10.1177/0897190014521996 CrossRefGoogle Scholar
  8. Bortolozzi A, Díaz-Mataix L, Scorza MC, Celada P, Artigas F (2005) The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J Neurochem 6:1597–1607CrossRefGoogle Scholar
  9. Boulougouris V, Robbins TW (2010) Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific. J Neurosci 30:930–938PubMedCrossRefGoogle Scholar
  10. Boulougouris V, Glennon JC, Robbins TW (2008) Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats. Neuropsychopharmacology 33:2007–2019PubMedCrossRefGoogle Scholar
  11. Dannon PN, Sasson Y, Hirschmann S, Iancu I, Grunhaus LJ, Zohar J (2000) Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial. Eur Neuropsychopharmacol 3:165–169CrossRefGoogle Scholar
  12. Dantzer R, Terlouw C, Tazi A, Koolhaas JM, Bohus B, Koob GF, Le Moal M (1988) The propensity for schedule-induced polydipsia is related to differences in conditioned avoidance behaviour and in defense reactions in a defeat test. Physiol Behav 43:269–273PubMedCrossRefGoogle Scholar
  13. De Leon J, Verghese C, Tracy JI, Jossiasen RC, Simpson GM (1994) Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol Psychiatry 35:408–419PubMedCrossRefGoogle Scholar
  14. De Leon J, Tracy JI, McCann E, McGrory A (2002) Polydipsia and schizophrenia in a psychiatric hospital: a replication study. Schizophr Res 57:293–301PubMedCrossRefGoogle Scholar
  15. Delgado PL, Moreno FA (1998a) Hallucinogens, serotonin and obsessive-compulsive disorder. J Psychoactive Drugs 30:359–366PubMedCrossRefGoogle Scholar
  16. Delgado PL, Moreno FA (1998b) Different roles for serotonin in anti-obsessional drug action and the pathophysiology of obsessive-compulsive disorder. Br J Psychiatry Suppl 35:21–25PubMedGoogle Scholar
  17. Didriksen M, Olsen GM, Christensen AV (1993) Effect of clozapine upon schedule-induced polydipsia (SIP) resembles neither the actions of dopamine D1 nor D2 blockade. Psychopharmacology 113:250–256PubMedCrossRefGoogle Scholar
  18. Dundas B, Harris M, Narasimhan M (2007) Psychogenic polydipsia review: etiology, differential, and treatment. Curr Psychiatry Rep 9:236–241PubMedCrossRefGoogle Scholar
  19. Economidou D, Theobald DE, Robbins TW, Everitt BJ, Dalley JW (2012) Norepinephrine and dopamine modulate impulsivity on the five-choice serial reaction time task through opponent actions in the shell and core sub-regions of the nucleus accumbens. Neuropsychopharmacology 9:2057–2066. doi: 10.1038/npp.2012.53 CrossRefGoogle Scholar
  20. El Mansari M, Blier P (2006) Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 30:362–373PubMedCrossRefGoogle Scholar
  21. Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L (2005) Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Eur Neuropsychopharmacol 1:69–74CrossRefGoogle Scholar
  22. Evenson RC, Jos CJ, Mallya AR (1987) Prevalence of polydipsia among public psychiatric patients. Psychol Rep 60:803–807PubMedCrossRefGoogle Scholar
  23. Falk JL (1961) Production of polydipsia in normal rats by an intermittent food schedule. Science 133:195–196. doi: 10.1126/science.133.13447.195 PubMedCrossRefGoogle Scholar
  24. Falk JL (1966) The motivational properties of schedule-induced polydipsia. J Exp Anal Behav 9:19–25. doi: 10.1901/jeab.1966.9-19 PubMedCentralPubMedCrossRefGoogle Scholar
  25. Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E (2010) Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 35:591–604. doi: 10.1038/npp.2009.185 PubMedCentralPubMedCrossRefGoogle Scholar
  26. Fineberg NA, Chamberlain SR, Hollander E, Boulougouris V, Robbins TW (2011) Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment. Br J Pharmacol 4:1044–1061. doi: 10.1111/j.1476-5381.2011.01422.x CrossRefGoogle Scholar
  27. Fletcher PJ, Tampakeras M, Sinyard J, Higgins GA (2007) Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology 195:223–234PubMedCrossRefGoogle Scholar
  28. Gilpin NW, Badia-Elder NE, Elder RL, Stewart RB (2008) Schedule-induced polydipsia in lines of rats selectively bred for high and low ethanol preference. Behav Genet 38:515–524. doi: 10.1007/s10519-008-9224-1 PubMedCentralPubMedCrossRefGoogle Scholar
  29. Gobert A, Millan MJ (1999) Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38(2):315–317PubMedCrossRefGoogle Scholar
  30. Goddard AW, Shekhar A, Whiteman AF, McDougle CJ (2008) Serotonergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discov Today 13:325–332PubMedCrossRefGoogle Scholar
  31. Gross-Isseroff R, Cohen R, Sasson Y, Voet H, Zohar J (2004) Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan. Neuropsychobiology 50:200–205PubMedCrossRefGoogle Scholar
  32. Hadamitzky M, Feja M, Becker T, Koch M (2009) Effects of acute systemic administration of serotonin 2A/C receptor ligands in a delay-based decision-making task in rats. Behav Pharmacol 20:415–423. doi: 10.1097/FBP.0b013e3283305e11 PubMedCrossRefGoogle Scholar
  33. Hawken ER, Beninger RJ (2013) The amphetamine sensitization model of schizophrenia symptoms and its effects on schedule-induced polydipsia in the rat. Psychopharmacology. doi: 10.1007/s00213-013-3345-9 PubMedGoogle Scholar
  34. Hawken ER, Delva NJ, Reynolds JN, Beninger RJ (2011) Increased schedule-induced polydipsia in the rat following subchronic treatment with MK-801. Schizophr Res 125:93–98. doi: 10.1016/j.schres.2010.07.022 PubMedCrossRefGoogle Scholar
  35. Ibias J, Pellón R (2014) Different relations between schedule-induced polydipsia and impulsive behaviour in the spontaneously hypertensive Rat and in high impulsive Wistar rats: questioning the role of impulsivity in adjunctive behaviour. Behav Brain Res 271:184–194PubMedCrossRefGoogle Scholar
  36. Killeen PR, Pellón R (2013) Adjunctive behaviors are operants. Learn Behav 41:1–24. doi: 10.3758/s13420-012-0095-1 PubMedCrossRefGoogle Scholar
  37. Klein AB, Ultved L, Adamsen D, Santini MA, Tobeña A, Fernandez-Teruel A, Flores P, Moreno M, Cardona D, Knudsen GM, Aznar S, Mikkelsen JD (2014) 5-HT2A and mGlu2 receptor binding levels are related to differences in impulsive behavior in the Roman Low- (RLA) and high- (RHA) avoidance rat strains. Neuroscience 263:36–45. doi: 10.1016/j.neuroscience.2013.12.063 PubMedCrossRefGoogle Scholar
  38. Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M (2004) Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. Naunyn Schmiedebergs Arch Pharmacol 2:114–123Google Scholar
  39. Koskinen T, Ruotsalainen S, Puumala T, Lappalainen R, Koivisto E, Männistö PT, Sirviö J (2000) Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology 39:471–481PubMedCrossRefGoogle Scholar
  40. Kuroki T, Meltzer HY, Ichikawa J (2003) 5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res 972:216–221Google Scholar
  41. López-Grancha M, Lopez-Crespo G, Sanchez-Amate MC, Flores P (2008) Individual differences in schedule-induced polydipsia and the role of gabaergic and dopaminergic systems. Psychopharmacology 197:487–498. doi: 10.1007/s00213-007-1059-6 PubMedCrossRefGoogle Scholar
  42. Martin JR, Bös M, Jenck F, Moreau J, Mutel V, Sleight AJ, Wichmann J, Andrews JS, Berendsen HH, Broekkamp CL, Ruigt GS, Köhler C, Delft AM (1998) 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 286:913–924PubMedGoogle Scholar
  43. Martin JR, Ballard TM, Higgins GA (2002) Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety. Pharmacol Biochem Behav 71:615–625PubMedCrossRefGoogle Scholar
  44. McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH (2000) A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 8:794–801CrossRefGoogle Scholar
  45. Mittleman G, Jones GH, Robbins TW (1988a) The relationship between schedule-induced polydipsia and pituitary-adrenal activity: pharmacological and behavioral manipulations. Behav Brain Res 28:315–324PubMedCrossRefGoogle Scholar
  46. Mittleman G, Jones GH, Robbins TW (1988b) Effects of diazepam, FG 7142, and RO 15–1788 on schedule-induced polydipsia and the temporal control of behavior. Psychopharmacology 94:103–109PubMedCrossRefGoogle Scholar
  47. Mittleman G, Rosner AL, Schaub CL (1994) Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists. J Pharmacol Exp Ther 271:638–650PubMedGoogle Scholar
  48. Mittleman G, Van Brunt CL, Matthews DB (2003) Schedule-induced ethanol self-administration in DBA/2J and C57BL/6J mice. Alcohol Clin Exp Res 27:918–925PubMedCrossRefGoogle Scholar
  49. Mittleman G, Call SB, Cockroft JL, Goldowitz D, Matthews DB, Blaha CD (2011) Dopamine dynamics associated with, and resulting from, schedule-induced alcohol self-administration: analyses in dopamine transporter knockout mice. Alcohol 45:325–339. doi: 10.1016/j.alcohol.2010.12.006 PubMedCentralPubMedCrossRefGoogle Scholar
  50. Moreno M, Flores P (2012) Schedule-induced polydipsia as a model of compulsive behavior: neuropharmacological and neuroendocrine bases. Psychopharmacology 219:647–659. doi: 10.1007/s00213-011-2570-3 PubMedCrossRefGoogle Scholar
  51. Moreno M, Cardona D, Gómez MJ, Sánchez-Santed F, Tobeña A, Fernández-Teruel A, Campa L, Suñol C, Escarabajal MD, Torres C, Flores P (2010) Impulsivity characterization in the Roman high- and low-avoidance rat strains: behavioral and neurochemical differences. Neuropsychopharmacology 35:1198–1208. doi: 10.1038/npp.2009.224 PubMedCentralPubMedCrossRefGoogle Scholar
  52. Moreno M, Gutiérrez-Ferre VE, Ruedas L, Campa L, Suñol C, Flores P (2012) Poor inhibitory control and neurochemical differences in high compulsive drinker rats selected by schedule-induced polydipsia. Psychopharmacology 219:661–672. doi: 10.1007/s00213-011-2575-y Nov 24 PubMedCrossRefGoogle Scholar
  53. Oades RD, Daniels R, Rascher W (1998) Plasma neuropeptide-Y levels, monoamine metabolism, electrolyte excretion and drinking behaviour in children with attention-deficit hyperactivity disorder. Psychiatry Res 80:177–186PubMedCrossRefGoogle Scholar
  54. Pellón R, Ruíz A, Moreno M, Claro F, Ambrosio E, Flores P (2011) Individual differences in schedule-induced polydipsia: neuroanatomical dopamine divergences. Behav Brain Res 217:195–201. doi: 10.1016/j.bbr.2010.10.010 PubMedCrossRefGoogle Scholar
  55. Perani D, Garibotto V, Gorini A, Moresco RM, Henin M, Panzacchi A, Matarrese M, Carpinelli A, Bellodi L, Fazio F (2008) In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. Neuroimage 42:306–314. doi: 10.1016/j.neuroimage.2008.04.233 PubMedCrossRefGoogle Scholar
  56. Platt B, Beyer CE, Schechter LE, Rosenzweig-Lipson S (2008) Schedule-induced polydipsia: a rat model of obsessive-compulsive disorder. Curr Protoc Neurosci. ; Chapter 9:Unit 9.27. doi: 10.1002/0471142301.ns0927s43
  57. Robbins TW, Crockett, MJ (2010) Role of central serotonin in impulsivity and compulsivity: comparative studies in experimental animals and humans. In: Müller C and Jacobs B (eds) Handbook of behavioral neuroscience. Elsevier CIUDAD, Vol 21, pp 415–42Google Scholar
  58. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X, Dalley JW, Robbins TW (2008) Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33:1028–1037PubMedCrossRefGoogle Scholar
  59. Rosenzweig-Lipson S, Sabb A, Stack G, Mitchell P, Lucki I, Malberg JE, Grauer S, Brennan J, Cryan JF, Sukoff Rizzo SJ, Dunlop J, Barrett JE, Marquis KL (2007) Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents. Psychopharmacology 192:159–170PubMedCrossRefGoogle Scholar
  60. Rueter LE, Tecott LH, Blier P (2000) In vivo electrophysiological examination of 5-HT2 responses in 5-HT2C receptor mutant mice. Naunyn Schmiedebergs Arch Pharmacol 5:484–491CrossRefGoogle Scholar
  61. Schechter LE, Lin Q, Smith DL, Zhang G, Shan Q, Platt B, Brandt MR, Dawson LA, Cole D, Bernotas R, Robichaud A, Rosenzweig-Lipson S, Beyer CE (2008) Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology 6:1323–1335CrossRefGoogle Scholar
  62. Schepisi C, De Carolis L, Nencini P (2013) Effects of the 5HT2C antagonist SB242084 on the pramipexole-induced potentiation of water contrafreeloading, a putative animal model of compulsive behavior. Psychopharmacology 227:55–66. doi: 10.1007/s00213-012-2938-z PubMedCrossRefGoogle Scholar
  63. Simpson HB, Slifstein M, Bender J Jr, Xu X, Hackett E, Maher MJ, Abi-Dargham A (2011) Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL100907. Biol Psychiatry 70:897–904. doi: 10.1016/j.biopsych.2011.06.023 PubMedCentralPubMedCrossRefGoogle Scholar
  64. Skodol AE, Oldham JM (1996) Phenomenology, differential diagnosis, and comorbidity of impulsive-compulsive spectrum of disorders. In: Oldham JM, Hollander E, Skodol AE (eds) Impulsivity and compulsivity. American Psychiatric Press, Inc., Washington DC, pp 1–36Google Scholar
  65. Tanaka Y, Rohde LA, Jin L, Feldman PD, Upadhyaya HP (2013) A meta-analysis of the consistency of atomoxetine treatment effects in pediatric patients with attention-deficit/hyperactivity disorder from 15 clinical trials across four geographic regions. J Child Adolesc Psychopharmacol 23:262–270. doi: 10.1089/cap.2012.0049 PubMedCrossRefGoogle Scholar
  66. Toscano CA, Kamevama M, García-Mijares M, Silva MT, Santarem EM (2008) Relationship between ethanol and sucrose sel-administration and schedule-induced polydipsia. Pharmacol Biochem Behav 90:586–589. doi: 10.1016/j.pbb.2008.04.019 PubMedCrossRefGoogle Scholar
  67. Verghese C, de Leon J, Josiassen RC (1996) Problems and progress in the diagnosis and treatment of polydipsia and hyponatremia. Schizophr Bull 22:455–464PubMedCrossRefGoogle Scholar
  68. Vermeire S, Audenaert K, De Meester R, Vandermeulen E, Waelbers T, De Spiegeleer B, Eersels J, Dobbeleir A, Peremans K (2012) Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder. Psychiatry Res 1:78–87. doi: 10.1016/j.pscychresns.2011.06.006 CrossRefGoogle Scholar
  69. Wayner MJ (2002) Craving for alcohol in the rat: adjunctive behavior and the lateral hypothalamus. Pharmacol Biochem Behav 73:27–43PubMedCrossRefGoogle Scholar
  70. Westenberg HG, Fineberg NA, Denys D (2007) Neurobiology of obsessive-compulsive disorder: serotonin and beyond. CNS Spectr 12:14–27Google Scholar
  71. Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW (2004) 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology 176:376–385PubMedCrossRefGoogle Scholar
  72. Woods A, Smith C, Szewczak M, Dunn RW, Cornfeldt M, Corbett R (1993) Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder. Psychopharmacology 112:195–198PubMedCrossRefGoogle Scholar
  73. Woods-Kettelberger A, Kongsamut S, Smith CP, Winslow JT, Corbett R (1997) Animal models with potential applications for screening compounds for the treatment of obsessive-compulsive disorder. Expert Opin Investig Drugs 10:1369–1381CrossRefGoogle Scholar
  74. Zohar J, Chopra M, Sasson Y, Amiaz R, Amital D (2000) Obsessive compulsive disorder: serotonin and beyond. World J Biol Psychiatry 2:92–100CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Silvia Victoria Navarro
    • 1
  • Valeria Gutiérrez-Ferre
    • 1
  • Pilar Flores
    • 1
  • Margarita Moreno
    • 1
  1. 1.Department of PsychologyUniversity of Almería, Campus de Excelencia Internacional Agroalimentario CeiA3AlmeríaSpain

Personalised recommendations